Kidney disease drug trial pulled before it began
Disease control
Terminated
This study aimed to test an experimental drug called VAR200 in adults with type 2 diabetes and kidney disease. The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage. However, the trial was withdrawn before any participants were enrolled, so no…
Phase: PHASE2 • Sponsor: ZyVersa Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC